Felty's syndrome

C Wegscheider, V Ferincz, K Schöls… - Frontiers in Medicine, 2023 - frontiersin.org
Felty's syndrome was first described in 1924 by the US-American physician Augustus Roi
Felty as a triad of rheumatoid arthritis, splenomegaly and leucopenia. Even nearly 100 years …

Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders

J Bleesing - Frontiers in Immunology, 2022 - frontiersin.org
In this article, we will share lessons that patients with gain-of-function defects in Toll-like
receptor 8 (TLR8-GOF) can teach us about the interface between bone marrow failure (BMF) …

Low-risk myelodysplastic syndrome revisited: morphological, autoimmune, and molecular features as predictors of outcome in a single center experience

B Fattizzo, GV Levati, JA Giannotta… - Frontiers in …, 2022 - frontiersin.org
Low-risk myelodysplastic syndromes (LR-MDS) are a very heterogeneous disease, with
extremely variable clinical features and outcome. Therapeutic strategies are still limited and …

[HTML][HTML] Cymbopogon citratus protect against lead-induced suppression of haematological and tubuloglomerular functions as well as disruption of hepatocellular …

HO Eruotor, JN Asiwe, TM Eruotor - Journal of trace elements and minerals, 2023 - Elsevier
Background Liver and kidney damage associated with lead acetate exposure has been
reported to involve membrane disruption and renal tubuloglomerular dysfunctions which …

Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling

M Kavesh, M Mohebnasab, MR Angel, W Xie… - Blood …, 2023 - ashpublications.org
Next-generation sequencing (NGS) has demonstrated the existence of recurrent activating
mutations in STAT3 and STAT5B in~ 40% to 50% of patients with T-cell large granular …

[HTML][HTML] Tuberculosis-induced aplastic crisis and atypical lymphocyte expansion in advanced myelodysplastic syndrome: A case report and review of literature

XY Sun, XD Yang, J Xu, NN Xiu, B Ju… - World Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Myelodysplastic syndrome (MDS) is caused by malignant proliferation and
ineffective hematopoiesis. Oncogenic somatic mutations and increased apoptosis …

LGL clonal expansion and unexplained cytopenia: two clues don't make an evidence

G Calabretto, E Attardi, C Gurnari, G Semenzato… - Cancers, 2022 - mdpi.com
Simple Summary The clonal expansions of large granular lymphocytes are frequently
detected in a wide spectrum of hematological and immune diseases. This clinical overlap …

Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3

S Park, J Yun, SY Choi, D Jeong, JY Gu, JS Lee… - Scientific Reports, 2023 - nature.com
T-cell large granular lymphocyte leukemia (T-LGL) is often accompanied by pure red cell
aplasia (PRCA). A high depth of next generation sequencing (NGS) was used for detection …

T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS)

R Di Napoli, N Balzano, R Ruggiero… - Expert Opinion on …, 2025 - Taylor & Francis
Background Concern about post-CAR T-cell lymphomas has recently emerged. Analysis of
pharmacovigilance data contributes to continuous safety monitoring, especially for newly …

A novel vaccine strategy to prevent cytauxzoonosis in domestic cats

P Weerarathne, R Maker, C Huang, B Taylor… - Vaccines, 2023 - mdpi.com
Cytauxzoonosis is caused by Cytauxzoon felis (C. felis), a tick-borne parasite that causes
severe disease in domestic cats in the United States. Currently, there is no vaccine to …